Cargando…

DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical–protein interactome

Identifying new indications for existing drugs (drug repositioning) is an efficient way of maximizing their potential. Adverse drug reaction (ADR) is one of the leading causes of death among hospitalized patients. As both new indications and ADRs are caused by unexpected chemical–protein interaction...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Heng, Chen, Jian, Shi, Leming, Mikailov, Mike, Zhu, Huang, Wang, Kejian, He, Lin, Yang, Lun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2011
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3125745/ https://www.ncbi.nlm.nih.gov/pubmed/21558322 http://dx.doi.org/10.1093/nar/gkr299

Ejemplares similares

DPDR-CPI, a server that predicts Drug Positioning and Drug Repositioning via Chemical-Protein Interactome
por: Luo, Heng, et al.
Publicado: (2016)

DDI-CPI, a server that predicts drug–drug interactions through implementing the chemical–protein interactome
por: Luo, Heng, et al.
Publicado: (2014)

Exploring Off-Targets and Off-Systems for Adverse Drug Reactions via Chemical-Protein Interactome — Clozapine-Induced Agranulocytosis as a Case Study
por: Yang, Lun, et al.
Publicado: (2011)

SePreSA: a server for the prediction of populations susceptible to serious adverse drug reactions implementing the methodology of a chemical–protein interactome
por: Yang, Lun, et al.
Publicado: (2009)

Identifying Unexpected Therapeutic Targets via Chemical-Protein Interactome
por: Yang, Lun, et al.
Publicado: (2010)

Harvesting Candidate Genes Responsible for Serious Adverse Drug Reactions from a Chemical-Protein Interactome
por: Yang, Lun, et al.
Publicado: (2009)

Unraveling Gene Fusions for Drug Repositioning in High-Risk Neuroblastoma
por: Liu, Zhichao, et al.
Publicado: (2021)

Drug Repositioning for Noonan and LEOPARD Syndromes by Integrating Transcriptomics With a Structure-Based Approach
por: Zhu, Liyuan, et al.
Publicado: (2020)

Opportunities for Web-based Drug Repositioning: Searching for Potential Antihypertensive Agents with Hypotension Adverse Events
por: Wang, Kejian, et al.
Publicado: (2016)

Prediction of Drug-Target Interactions for Drug Repositioning Only Based on Genomic Expression Similarity
por: Wang, Kejian, et al.
Publicado: (2013)

Correction: Prediction of Drug-Target Interactions for Drug Repositioning Only Based on Genomic Expression Similarity
por: Wang, Kejian, et al.
Publicado: (2013)

368 Development of Interactome Network to Understand Adverse Drug Reactions for Antidepressant Medications
por: Patel, Beenish, et al.
Publicado: (2023)

Mining drug–target and drug–adverse drug reaction databases to identify target–adverse drug reaction relationships
por: Galletti, Cristiano, et al.
Publicado: (2021)

Systematic Drug Repositioning Based on Clinical Side-Effects
por: Yang, Lun, et al.
Publicado: (2011)

Drug ReposER: a web server for predicting similar amino acid arrangements to known drug binding interfaces for potential drug repositioning
por: Ab Ghani, Nur Syatila, et al.
Publicado: (2019)

Repositioning Drugs for Psychiatry
por: Akhondzadeh, Shahin
Publicado: (2020)

Drug repositioning prediction for psoriasis using the adverse event reporting database
por: Ko, Minoh, et al.
Publicado: (2023)

Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning
por: Adasme, Melissa F., et al.
Publicado: (2020)

Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
por: Zhu, Sha, et al.
Publicado: (2022)

Differential Interactome Based Drug Repositioning Unraveled Abacavir, Exemestane, Nortriptyline Hydrochloride, and Tolcapone as Potential Therapeutics for Colorectal Cancers
por: Beklen, Hande, et al.
Publicado: (2021)

Network-Based Inference Methods for Drug Repositioning
por: Chen, Hailin, et al.
Publicado: (2015)

A Review of Current In Silico Methods for Repositioning Drugs and Chemical Compounds
por: He, Binsheng, et al.
Publicado: (2021)

In silico drug repositioning based on the integration of chemical, genomic and pharmacological spaces
por: Chen, Hailin, et al.
Publicado: (2021)

Drug Repositioning for Diabetes Based on 'Omics' Data Mining
por: Zhang, Ming, et al.
Publicado: (2015)

Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs
por: Parisi, Daniele, et al.
Publicado: (2020)

CPI Hard Disk System
Publicado: (2017)

Scotch 777 6250 CPI
Publicado: (2017)

Drug repositioning for personalized medicine
por: Li, Yvonne Y, et al.
Publicado: (2012)

Network mirroring for drug repositioning
por: Park, Sunghong, et al.
Publicado: (2017)

Drug Repositioning for COVID-19
por: Benavides-Cordoba, Vicente
Publicado: (2020)

GREP: genome for REPositioning drugs
por: Sakaue, Saori, et al.
Publicado: (2019)

Transcriptome-Guided Drug Repositioning
por: Arakelyan, Arsen, et al.
Publicado: (2019)

Drug Repositioning in Friedreich Ataxia
por: Rufini, Alessandra, et al.
Publicado: (2022)

Adverse Drug Reactions
por: Turner, Paul
Publicado: (1988)

Adverse Drug Reactions
por: Criado, Paulo Ricardo
Publicado: (2016)

DeepCPI: A Deep Learning-based Framework for Large-scale in silico Drug Screening
por: Wan, Fangping, et al.
Publicado: (2019)

Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs
por: Liu, Mei, et al.
Publicado: (2012)

Systematic drug repositioning through mining adverse event data in ClinicalTrials.gov
por: Su, Eric Wen, et al.
Publicado: (2017)

Small molecule inhibitor screen identifies synergistic activity of the bromodomain inhibitor CPI203 and bortezomib in drug resistant myeloma
por: Siegel, Matthew B., et al.
Publicado: (2015)

Systematic Approach for Drug Repositioning of Anti-Epileptic Drugs
por: Ko, Younhee, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_v1068acppqp6e3b5s9d56vkal6